New drug trial aims to slow Alzheimer's by calming brain inflammation
NCT ID NCT04804241
Summary
This study is testing whether a drug called Senicapoc can slow the progression of early Alzheimer's disease. Researchers believe it works by reducing inflammation in the brain. The trial will involve about 55 people with mild memory problems or early Alzheimer's, who will take either the drug or a placebo for one year. The main goal is to see if the drug improves memory test scores and lowers signs of inflammation in the blood and spinal fluid.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UC Davis Alzheimer's Disease Center East Bay
RECRUITINGWalnut Creek, California, 94598, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of California, Davis Alzheimer's Disease Center
RECRUITINGSacramento, California, 95817, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.